These findings highlight the potential of ATOMSSUISpenta as a subunit vaccine strategy with potential for broader protection against S. suis and demonstrate the effectiveness of epitope-based multimeric design in targeting antigenically diverse Gram-positive pathogens.
Kim et al. (Mon,) studied this question.